Project Details

Professor Dr. Lars Nitschke

Address Friedrich-Alexander-Universität Erlangen-Nürnberg
Naturwissenschaftliche Fakultät
Department Biologie
Staudtstraße 5
91058 Erlangen

Projects

As Applicant
- Current projects
  - The importance of sialoglycans for lymphocyte development and function (Research Units)
  - CD22 and its regulation of BCR signaling strength in germinal center B cell fate and metabolism (Research Units)
- Completed projects
  - Regulation of differentiation in myeloid cells and B-cells by the adhesion recepters of the siglec family (Research Grants)
  - Analysis of the role of the B cell inhibitory receptor Siglec-G in autoimmunity and infection models (Research Grants)
  - Untersuchungen zur Rolle von CD22 und Siglec-G in der Regulation von B-Zell-Aktivierung und systemischer Autoimmunität (Research Units)
  - Die Rolle des Adaptorproteins Grb2 für die Reifung und Aktivierung von B- und T-Lymphozyten (Research Grants)
As Spokesperson
- Completed projects
  - TRR 130: B Cells: Immunity and Autoimmunity (CRC/Transregios)
As Participating Researcher
- Current projects
  - GRK 2599: FAIR - Fine-Tuners of the Adaptive Immune Response (Research Training Groups)
- Completed projects
  - GRK 592: Lymphocytes: Differentiation, Activation and Deviation (Research Training Groups)
  - GRK 1660: Key Signals of Adaptive Immune Response (Research Training Groups)
As Project Head
- Current projects
  - The role of Siglecs and sialic acids in the resolution of inflammation (Collaborative Research Centres)
- Completed projects
  - Regulation von Differenfzierungsentscheidungen in der myeloiden und B-Zell-Linie durch Adhäsionsrezeptoren der Siblec-Familie (Collaborative Research Centres)
  - Untersuchungen zur Rolle von CD22 und Siglecs in der B-Zell-Differenzierung und B-Zell-Signalleitung mit Hilfe genetisch-veränderter Mäuse (Collaborative Research Centres)
  - Neu-entwickelte Sialinsäurederivate zur Verstärkung der B-Zellaktivierung über CD22 und deren möglicher therapeutischer Einsatz (Collaborative Research Centres)
  - Targeting of CD22 on B cell lymphoma cells and on B cells in autoimmune diseases (Collaborative Research Centres)
  - Transgenic mouse unit (CRC/Transregios)
  - The role of Siglec proteins in B cell activation and autoimmunity (CRC/Transregios)
  - Central Tasks (CRC/Transregios)

Servicenavigation

Hauptnavigation

Professor Dr. Lars Nitschke

Additional Information

Servicenavigation

Hauptnavigation

Professor Dr. Lars Nitschke

Additional Information

Textvergrößerung und Kontrastanpassung